MedTrace Logo

Autologous Platelet Lysate in Corneal Epithelial Defects

NCT02979912 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-03-03

No results posted yet for this study

Summary

Patients diagnosed with persistent corneal epithelial ulcers will be treated with autologous platelet lysate.

Conditions

  • Persistent Corneal Epithelial Defect

Interventions

BIOLOGICAL

Platelet Lysate

Eye drops of Platelet Lysate

Sponsors & Collaborators

  • Hanan Jafar

    lead OTHER

Principal Investigators

  • Abdallah Awidi, MD · Cell Therapy Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-16
Primary Completion
2019-01-15
Completion
2019-01-30

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02979912 on ClinicalTrials.gov